Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
TEPCO
Pilot Study Evaluating the Feasibility and Appropriateness of a Telerehabilitation Exercise Program in People With Post-COVID-19 Sequelae: a Single-center Randomized Trial.
2 other identifiers
interventional
22
1 country
1
Brief Summary
The goal of this study pilot randomized controlled study is to evaluate the feasibility of the study procedures and to compare the preliminary efficacy of a rehabilitation program given in a "remote" (telerehabilitation) or "face-to-face" model for adult patients who had confirmed SARS-CoV-2 infection and still have symptoms after eight weeks of infection. The main question it aims to answer is:
- Are the study procedures feasible?
- Will the two groups have similar results for the preliminary efficacy outcomes? Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable. Participants will:
- Take part in a 60-minute training session, 3 times a week in person or remotely
- Visit the clinic before starting the training program and after 8 weeks of training
- Keep a diary of their symptoms, if any
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 29, 2024
CompletedFirst Submitted
Initial submission to the registry
April 24, 2025
CompletedFirst Posted
Study publicly available on registry
April 30, 2025
CompletedApril 30, 2025
April 1, 2025
12 months
April 24, 2025
April 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The feasibility of study procedures
This will be evaluated by % of participants that accept to participate in the study (recruitment rate), % of participants who drop out or withdraw from a study (attrition rate), % completed session (adherence rate); number of adverse events and % of participants satisfaction.
8 weeks
Secondary Outcomes (7)
Exercise capacity
8 weeks
Walking capacity
8 weeks
Lower-limb endurance
8 weeks
Physical performance
8 weeks
Change in Independence in activities of daily living
8 weeks
- +2 more secondary outcomes
Study Arms (2)
Telerehabilitation group
EXPERIMENTALRehabilitation program including cardiovascular, muscular and balance training and, if necessary, respiratory physiotherapy using the Teams platform supervised by a certified kinesiologist. The rehabilitation will be conducted 3 times a week for 8 weeks in group of 5 or 6 persons.
Face-to-face group
ACTIVE COMPARATORRehabilitation program including cardiovascular, muscular and balance training and, if necessary, respiratory physiotherapy at the university kinesiology clinic supervised by a certified kinesiologist. The rehabilitation will be conducted 3 times a week for 8 weeks in group of 5 or 6 persons.
Interventions
* 5-minute warm-up including easy global exercises * 5 resistance training exercises targeting upper and lower muscle groups * 30 secondes break between sets * Cooldown with breathing and stretching exercises
Eligibility Criteria
You may qualify if:
- adult patients (≥18 years)
- confirmed SARS-CoV-2 infection defined by positive polymerase chain reaction (PCR) testing and/or antigen test results
- referred to the pneumology clinic for a modified British Medical Research Council (mMRC) dyspnea score of 2-3 after a minimum of eight weeks of infection
- VO₂max of less than 80% of the predicted value
- receiving a medical prescription for rehabilitation following initial assessment by a pulmonologist
- being able to walk independently
- providing informed consent
- having a good internet connection (i.e., a minimum download speed of 4 Mbps and an upload speed of 4 Mbps)
- being in possession of a computer or tablet equipped with a camera enabling videoconferencing.
You may not qualify if:
- requiring in-hospital rehabilitation at discharge
- evidence of medical instability (i.e., moderate or severe cardiac disease, ischemic or severe hemorrhagic stroke, or neurodegenerative disease, unstable fracture)
- history of severe cognitive or mental impairment
- already enrolled in another rehabilitation program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre hospitalier affilié universitaire régional
Trois-Rivières, Quebec, G8Z 3R9, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 24, 2025
First Posted
April 30, 2025
Study Start
April 7, 2023
Primary Completion
March 29, 2024
Study Completion
March 29, 2024
Last Updated
April 30, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share